SCHEMBL20103363

SCHEMBL20103363

COC(=O)C(C)(F)Cc1cccc(N=C(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
CTRB1 P17538 1/20 0.38
MAP2K5 Q13163 1/20 0.37
MAPK7 Q13164 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SRC P12931 1/20 0.37
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
KCNN4 O15554 1/20 0.36
PTPRB P23467 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
AAK1 Q2M2I8 1/20 0.36
PTPN1 P18031 1/20 0.35
CETP P11597 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28808224 0.79 CTRB1 (0.50) CTRB1MEN1KMT2ASRCKCNN4
SCHEMBL20103531 0.75 PDK1 (0.48) CTRB1MEN1KMT2APTPRBMRGPRX4
SCHEMBL20103587 0.75 PTPRB (0.40) CTRB1MEN1KMT2APTPRBMRGPRX4
SCHEMBL20103481 0.75 SIRT2 (0.46) MAP2K5MAPK7MEN1KMT2ANOS1
SCHEMBL20103561 0.74 CYP4F2 (0.43) CTRB1MEN1KMT2APTPRBMRGPRX4
SCHEMBL20103512 0.72 PTPRB (0.46) MEN1KMT2APTPRBPTPN1
SCHEMBL21688306 0.71 FFAR1 (0.41) ESR1ESR2MEN1KMT2ASRC
SCHEMBL20103376 0.71 FFAR1 (0.41) ESR1ESR2MEN1KMT2ASRC
SCHEMBL20103651 0.71 PTPRB (0.39) CTRB1MEN1KMT2APTPRBMRGPRX4
SCHEMBL4492960 0.70 ITGB3 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081047-A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed